UK Home Academics Athletics Medical Center Research Site Index Search UK
UK Emergency Rescue Helicopter College of Medicine Department Logo  
click here to view a link
Dr. Garvy

Department of Microbiology, Immunology and Molecular Genetics

Beth A. Garvy, Ph.D.

Assistant Professor

Doctoral studies: Michigan State University.

Postdoctoral: University of Miami Medical School and Trudeau Institute.

Dr. Garvy

Office phone: (859)323-5043
Fax: (859)323-1020
Lab phone: (859)323-9547

Email

Selected publications

Research statement: Pneumocystis carinii is an opportunistic fungal pathogen that can cause pneumonia in immunosuppressed individuals including AIDS patients.  It has been known for a number of years that an intact CD4 T cell compartment is critical for defense against P. carinii.  However, there are a number of questions regarding the immune response to P. carinii that are still unresolved.  The focus of our work is to examine the immune response to P. carinii using a murine model of infection.  There are two major questions that are being addressed:

1.  What is the role of B cells in the immune response to P. carinii?  It has not been fully appreciated that B cell function is as critical to host defense against P. carinii as is CD4 T cell function.  Mice that are deficient in B cells but have normal T cells will succumb to P. carinii pneumonia.  Clearly there is a role for P.carinii-specific antibody in clearance of the infection.  However, B cells have a variety other of functions such as cytokine production and antigen presentation.  We have been using a chimeric mouse model in which we generate mice that have a deficiency in a specific molecule on B cells.  We have determined that MHC class II must be present on B cells for clearance of P. carinii.  In addition, expression of CD40 on B cells is also required for clearance of the infection.  Interestingly, neither MHC class II nor CD40 deficient chimeras were able to produce P. carinii-specific IgG.  We are currently using a chimeras, adoptive transfers, and transgenic mice to determine whether B cells are required during early T cell priming events or whether the downstream production of IgG is the major role of B cells in resisting P. carinii infection.

2.  How do neonatal mice handle infection with P. carinii?  It has recently been noted that an unusually large proportion of babies that died of SIDS had P. carinii organisms in their lungs.  Although P. carinii infection is not likely the cause of SIDS, this data does suggest that neonates may be carriers of the organisms.  We have been using a murine model of P. carinii infection to examine neonatal immunity in the lungs.  Interestingly, mice infected as neonates take three weeks to mount an inflammatory response to P. carinii whereas adult mice given a comparable infectious dose respond within 3-5 days and clear the infection within 2-3 weeks.  We have found that T cells isolated from neonatal mice are able to effect clearance of P. carinii when transferred to an adult lung environment.  This has led us to more closely scrutinize the neonatal lung environment.  We have found that proinflammatory cytokines and chemokines are deficient in neonatal lungs however TGFb and IL-10, both anti-inflammatory, are elevated.  In addition, dendritic cells in neonatal lungs do not mature and migrate to draining lymph nodes with the same efficiency as dendritic cells in adult lungs.  Currently, we are using a variety of techniques including RNase protection assays and DNA arrays to identify molecules that may be involved in active suppression of immune responses taking place in the lungs of neonates.


.

Search COM
 
Comments to Jeff Lynn, Last Modified: Tuesday, October 03, 2006
Copyright © 2004, University of Kentucky Chandler Medical Center
Terms, Conditions & Privacy Statement
An Equal Opportunity University